TRU HPSA Trademark

Trademark Overview

On Tuesday, June 6, 2006, a trademark application was filed for TRU HPSA with the United States Patent and Trademark Office. The USPTO has given the TRU HPSA trademark a serial number of 78901818. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 8, 2010. This trademark is owned by Meridian Bioscience, Inc.. The TRU HPSA trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic tests for qualitative diagnosis in the medical or clinical laboratory for the detection of H pylori antigens in human stool to aid in the diagnosis of H pylori infection and to demonstrate loss of helicobacter pylon stool antigen following treatment
tru hpsa

General Information

Serial Number78901818
Word MarkTRU HPSA
Filing DateTuesday, June 6, 2006
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 8, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2007

Trademark Statements

Goods and ServicesDiagnostic tests for qualitative diagnosis in the medical or clinical laboratory for the detection of H pylori antigens in human stool to aid in the diagnosis of H pylori infection and to demonstrate loss of helicobacter pylon stool antigen following treatment

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 12, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMeridian Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45244
Party NameMeridian Bioscience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCincinnati, OH 45244

Trademark Events

Event DateEvent Description
Monday, November 8, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 8, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 20, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 19, 2010EXTENSION 5 GRANTED
Wednesday, April 7, 2010EXTENSION 5 FILED
Wednesday, April 7, 2010TEAS EXTENSION RECEIVED
Thursday, September 24, 2009EXTENSION 4 GRANTED
Monday, September 14, 2009EXTENSION 4 FILED
Thursday, September 24, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 14, 2009TEAS EXTENSION RECEIVED
Monday, March 23, 2009EXTENSION 3 GRANTED
Monday, March 23, 2009EXTENSION 3 FILED
Monday, March 23, 2009TEAS EXTENSION RECEIVED
Wednesday, October 8, 2008EXTENSION 2 GRANTED
Wednesday, October 8, 2008EXTENSION 2 FILED
Wednesday, October 8, 2008TEAS EXTENSION RECEIVED
Friday, April 4, 2008EXTENSION 1 GRANTED
Friday, April 4, 2008EXTENSION 1 FILED
Friday, April 4, 2008TEAS EXTENSION RECEIVED
Tuesday, October 9, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 17, 2007PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2007NOTICE OF PUBLICATION
Tuesday, June 12, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, June 9, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 2, 2007AMENDMENT FROM APPLICANT ENTERED
Wednesday, May 2, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 2, 2007ASSIGNED TO LIE
Wednesday, April 4, 2007PAPER RECEIVED
Tuesday, November 7, 2006NON-FINAL ACTION E-MAILED
Tuesday, November 7, 2006NON-FINAL ACTION WRITTEN
Tuesday, November 7, 2006ASSIGNED TO EXAMINER
Tuesday, June 13, 2006NOTICE OF PSEUDO MARK MAILED
Monday, June 12, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

hpsa pylori stool diagnosis demonstrate infection loss pylon treatment following antigen